ABT-147 is a humanized IgG1 monoclonal antibody inhibitor targeting IL-12. It is utilized in researching autoimmune diseases such as rheumatoid arthritis (RA), inflammatory diseases like inflammatory bowel disease (IBD), and other conditions including asthma.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
